| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Oct 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.26M | 29.83M | 30.99M | 35.22M | 14.39M | 10.71M |
| Gross Profit | 11.07M | 9.45M | 10.68M | 9.96M | 4.96M | 3.52M |
| EBITDA | 4.15M | 2.90M | 1.97M | 3.39M | 2.22M | 1.23M |
| Net Income | 1.79M | 637.00K | -914.00K | 1.26M | 967.00K | 475.00K |
Balance Sheet | ||||||
| Total Assets | 35.60M | 32.26M | 30.17M | 33.91M | 17.61M | 17.94M |
| Cash, Cash Equivalents and Short-Term Investments | 543.00K | 788.00K | 2.01M | 4.77M | 7.59M | 3.84M |
| Total Debt | 14.38M | 12.22M | 11.44M | 11.80M | 2.71M | 2.85M |
| Total Liabilities | 23.54M | 20.25M | 17.90M | 20.06M | 5.90M | 5.20M |
| Stockholders Equity | 12.06M | 12.01M | 12.27M | 13.85M | 11.71M | 12.74M |
Cash Flow | ||||||
| Free Cash Flow | -2.94M | -1.69M | -662.00K | -3.57M | 2.46M | 1.27M |
| Operating Cash Flow | -935.00K | -650.00K | 1.48M | -1.49M | 2.67M | 1.72M |
| Investing Cash Flow | -1.06M | 1.98M | -2.16M | -6.39M | 3.29M | 6.38M |
| Financing Cash Flow | 919.00K | -3.31M | -2.08M | 4.70M | -2.21M | -4.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £39.77M | -3.95 | 15.03% | ― | 16.66% | 147.92% | |
68 Neutral | £38.05M | 6.55 | 8.41% | 11.65% | -3.45% | -44.02% | |
64 Neutral | £33.54M | 7.91 | 8.31% | 7.98% | -3.45% | -35.25% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | £6.44M | 28.57 | 14.91% | 5.80% | -3.74% | ― | |
53 Neutral | £49.85M | -28.65 | -10.09% | 2.09% | -5.97% | 14.75% | |
48 Neutral | £11.99M | -1.63 | 0.16% | ― | -3.72% | ― |